Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001883076-24-000007·Coeptis Therapeutics Holdings, Inc.
Schedule 13G ownership disclosure
COEPTIS THERAPEUTICS HLDGS I
COMMON STOCK, PAR VALUE $0.0001 · CUSIP: 19207A108
Event date: 2024-01-05
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Leonite Fund I, LP
Shares: 2,050,000.00 · Class: 6.0%
- Leonite Advisors LLC
Shares: 2,050,000.00 · Class: 6.0%
- Geller Avi
Shares: 2,050,000.00 · Class: 6.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001883076-24-000007
- Form type
- SCHEDULE 13G
- Filer
- Coeptis Therapeutics Holdings, Inc.
- CIK
- CIK 1759186
- Filed
- Jan 11, 2024
- Reporting period
- Jan 05, 2024
- Description
- Schedule 13G beneficial ownership